- Home
- GLPG vs WWW Comparison
GLPG vs WWW Comparison
Compare GLPG & WWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPG
- WWW
- Stock Information
- Founded
- GLPG 1999
- WWW 1883
- Country
- GLPG Belgium
- WWW United States
- Employees
- GLPG N/A
- WWW N/A
- Industry
- GLPG Biotechnology: Pharmaceutical Preparations
- WWW Shoe Manufacturing
- Sector
- GLPG Health Care
- WWW Consumer Discretionary
- Exchange
- GLPG Nasdaq
- WWW Nasdaq
- Market Cap
- GLPG 1.9B
- WWW 1.0B
- IPO Year
- GLPG 2005
- WWW N/A
- Fundamental
- Price
- GLPG $30.52
- WWW $19.37
- Analyst Decision
- GLPG Sell
- WWW Buy
- Analyst Count
- GLPG 4
- WWW 6
- Target Price
- GLPG $25.33
- WWW $19.33
- AVG Volume (30 Days)
- GLPG 240.0K
- WWW 1.3M
- Earning Date
- GLPG 07-23-2025
- WWW 08-06-2025
- Dividend Yield
- GLPG N/A
- WWW 2.06%
- EPS Growth
- GLPG N/A
- WWW N/A
- EPS
- GLPG N/A
- WWW 0.90
- Revenue
- GLPG $311,493,731.00
- WWW $1,772,400,000.00
- Revenue This Year
- GLPG $0.78
- WWW $4.96
- Revenue Next Year
- GLPG N/A
- WWW $5.48
- P/E Ratio
- GLPG N/A
- WWW $21.65
- Revenue Growth
- GLPG 18.32
- WWW N/A
- 52 Week Low
- GLPG $22.36
- WWW $9.58
- 52 Week High
- GLPG $31.23
- WWW $24.64
- Technical
- Relative Strength Index (RSI)
- GLPG 68.07
- WWW 60.55
- Support Level
- GLPG $28.21
- WWW $19.04
- Resistance Level
- GLPG $30.64
- WWW $20.11
- Average True Range (ATR)
- GLPG 0.49
- WWW 0.67
- MACD
- GLPG 0.24
- WWW 0.01
- Stochastic Oscillator
- GLPG 91.59
- WWW 73.38
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.
About WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.